SANGAMO THERAPEUTICS, INC. Stock Issued During Period, Shares, Employee Stock Purchase Plans
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- SANGAMO THERAPEUTICS, INC. stock issued during period, shares, employee stock purchase plans for fiscal 2025 was 900.00K shares, a 28.57% increase from fiscal 2024.
- SANGAMO THERAPEUTICS, INC. stock issued during period, shares, employee stock purchase plans for fiscal 2024 was 700.00K shares, a 48.03% decline from fiscal 2023.
- SANGAMO THERAPEUTICS, INC. stock issued during period, shares, employee stock purchase plans for fiscal 2023 was 1.35M shares, a 133.44% increase from fiscal 2022.
- SANGAMO THERAPEUTICS, INC. stock issued during period, shares, employee stock purchase plans for fiscal 2022 was 576.95K shares, a 33.21% increase from fiscal 2021.
| Period end | Stock Issued During Period, Shares, Employee Stock Purchase Plans 3 month | Stock Issued During Period, Shares, Employee Stock Purchase Plans 12 month |
|---|---|---|
| 2025-12-31 | 900.00K shares 10-K · filed 2026-03-30 | |
| 2024-12-31 | 700.00K shares 10-K · filed 2026-03-30 | |
| 2023-12-31 | 1.35M shares 10-K · filed 2025-03-17 | |
| 2022-12-31 | 576.95K shares 10-K · filed 2024-03-13 | |
| 2021-12-31 | 433.11K shares 10-K · filed 2024-03-13 | |
| 2020-12-31 | 274.38K shares 10-K · filed 2023-02-23 | |
| 2019-12-31 | 249.36K shares 10-K · filed 2022-02-24 | |
| 2018-12-31 | 328.71K shares 10-K · filed 2021-02-24 | |
| 2017-12-31 | 253.99K shares 10-K · filed 2020-02-28 | |
| 2016-12-31 | 202.71K shares 10-K · filed 2019-03-01 | |
| 2015-12-31 | 128.18K shares 10-K · filed 2018-03-01 | |
| 2014-12-31 | 107.20K shares 10-K · filed 2017-02-28 | |
| 2013-12-31 | 180.55K shares 10-K · filed 2016-02-18 | |
| 2012-12-31 | 175.38K shares 10-K · filed 2015-02-25 |